Open AccessIs the Benefit of Antithrombotics and Statins Worth the Risk of Intracerebral Hemorrhage?
Author(s) -
Jose Gutierrez
Publication year - 2021
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.121.020460
Subject(s) - medicine , intensive care medicine , intracerebral hemorrhage , stroke (engine) , hydroxymethylglutaryl coa reductase inhibitors , medline , disease , risk assessment , antithrombotic , statin , rivaroxaban , diabetes mellitus , aspirin , risk factor , fibrinolytic agent , clinical trial , platelet aggregation inhibitor , anticoagulant , myocardial infarction , heart failure , atrial fibrillation , warfarin , neuroprotection , cardiology , number needed to treat , atherosclerotic cardiovascular disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom